Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

835 public trials 210 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Recruiting

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

NCT06807632

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

NCT06203210

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Clinical Research Providence Medical Foundation Fullerton, California, United States
  • UCLA Hematology-Oncology Los Angeles, California, United States
  • UCSF Mission Bay Mission Hall San Francisco, California, United States
View all 229 locations
View Trial Details
Recruiting

Tarlatamab for SCLC Brain Metastases

NCT07402343

Conditions
Brain Diseases, Brain Metastases, Adult, Brain Neoplasms, +15 more
Locations
  • The Netherlands Cancer Institute Amsterdam, Netherlands
  • University Medical Center Groningen Groningen, Netherlands
  • Maastricht UMC+ Maastricht, Netherlands
  • Erasmus MC Rotterdam, Netherlands
View Trial Details
Recruiting

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

NCT06095583

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-stage Small Cell Lung Cancer (LS-SCLC), +8 more
Locations
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Xiangya Hospital Central South University Changsha, Hunan, China
  • The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • The First Hospital of China Medical University Shenyang, Liaoning, China
View all 76 locations
View Trial Details

Related conditions